
The Prescription Medicines Code of Practice Authority | PMCPA
The Prescription Medicines Code of Practice Authority (PMCPA) is the self-regulatory body which administers the Association of the British Pharmaceutical Industry (ABPI) Code of Practice for the Pharmaceutical Industry, independently of the ABPI. It was established by the ABPI on 1 …
The ABPI Code of Practice for the Pharmaceutical Industry 2024 - PMCPA
relationships with patient organisations. Download a copy of the 2024 Code here.
Code of Practice for the Pharmaceutical Industry 2024
2024年9月23日 · In addition, it sets standards for the provision of information about prescription only medicines to the public and patients, including patient organisations. The Prescription Medicines Code of Practice Authority (PMCPA) is responsible for administering the ABPI Code of Practice for the pharmaceutical industry at arm's length of the ABPI itself.
Moderna slammed over posts ‘inappropriately directed’ at kids
2025年2月4日 · For the fourth time in five months, the Prescription Medicines Code of Practice Authority (PMCPA) has ruled that Moderna brought discredit on the pharma industry.
Novo Nordisk accepted back into ABPI after suspension lifted
22 小时之前 · ABPI said Monday that the suspension had been lifted after the Prescription Medicines Code of Practice Authority (PMCPA), the body that enforces the code, carried out “extensive audits of Novo ...
Four drugmakers found to have breached ABPI code
5 天之前 · Novartis, Pfizer, Otsuka and Novo Nordisk have been called out by the UK’s Prescription Medicines Code of Practice Authority (PMCPA) for breaching the Association of the British Pharmaceutical...
New ABPI Code and PMCPA Constitution and Procedure Published
2024年10月1日 · On 23 September 2024, the suspense finally lifted, with the publication of the ABPI Code 2024 (available here). The 2024 ABPI Code replaces the previous version from 2021. The new ABPI Code incorporates an updated PMCPA Constitution and Procedure, which sets out the procedure for adjudicating upon advertising complaints.
Press Release 17 February 2025 - pmcpa.org.uk
2025年2月17日 · AstraZeneca – Case AUTH/3729/1/23. For promoting capivasertib on LinkedIn prior to the grant of its marketing authorisation, in a post that contained the strong phrase ‘remarkable benefits’, and the impression created by very senior staff acting contrary to the company’s global social media policy, AstraZeneca was ruled in breach of the following clauses of the 2021 Code:
GSK rebuked as LinkedIn celebration breaks drug promotion rules
2025年2月21日 · The PMCPA has turned party pooper, coming down on GSK after learning that a U.K. employee celebrated a post about a prescription drug on LinkedIn. A panel of leaders at the PMCPA, pharma’s...
Q&As by Topic OR Clause - pmcpa-cloud.euwest01.umbraco.io
The PMCPA is a division of the ABPI which is a company limited by guarantee registered in England & Wales no 09826787. Registered office 2nd Floor Goldings House, Hay’s Galleria, 2 Hay’s Lane, London, SE1 2HB.